These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20829612)

  • 41. Constitutive somatostatin receptor activity determines tonic pituitary cell response.
    Ben-Shlomo A; Zhou C; Pichurin O; Chesnokova V; Liu NA; Culler MD; Melmed S
    Mol Endocrinol; 2009 Mar; 23(3):337-48. PubMed ID: 19131507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel subtype specific and universal somatostatin analogues: clinical potential and pitfalls.
    van der Hoek J; Hofland LJ; Lamberts SW
    Curr Pharm Des; 2005; 11(12):1573-92. PubMed ID: 15892663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1/2 activity.
    Treppiedi D; Giardino E; Catalano R; Mangili F; Vercesi P; Sala E; Locatelli M; Arosio M; Spada A; Mantovani G; Peverelli E
    Mol Cell Endocrinol; 2019 Mar; 483():31-38. PubMed ID: 30611770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cells.
    Treppiedi D; Di Muro G; Mangili F; Catalano R; Giardino E; Barbieri AM; Locatelli M; Arosio M; Spada A; Peverelli E; Mantovani G
    Mol Cell Endocrinol; 2021 Mar; 524():111159. PubMed ID: 33428965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The somatostatin receptor subtype 2 is expressed in normal and tumoral human tissues70.
    Prévost G; Benamouzig R; Veber N; Fajac A; Tatoud R; Degeorges A; Eden P
    Cancer Detect Prev; 1997; 21(1):62-70. PubMed ID: 9043765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. V3 vasopressin receptor and corticotropic phenotype in pituitary and nonpituitary tumors.
    de Keyzer Y; René P; Lenne F; Auzan C; Clauser E; Bertagna X
    Horm Res; 1997; 47(4-6):259-62. PubMed ID: 9167961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Somatostatin-dopamine chimeras: a novel approach to treatment of neuroendocrine tumors.
    Culler MD
    Horm Metab Res; 2011 Nov; 43(12):854-7. PubMed ID: 21989554
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition by somatostatin of ACTH secretion in Nelson's syndrome.
    Tyrrell JB; Lorenzi M; Gerich JE; Forsham PH
    J Clin Endocrinol Metab; 1975 Jun; 40(6):1125-7. PubMed ID: 166089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ten years on: Safety of short synacthen tests in assessing adrenocorticotropin deficiency in clinical practice.
    Gleeson HK; Walker BR; Seckl JR; Padfield PL
    J Clin Endocrinol Metab; 2003 May; 88(5):2106-11. PubMed ID: 12727962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vasoactive intestinal peptide stimulates hormone release from corticotropic cells in culture.
    Westendorf JM; Phillips MA; Schonbrunn A
    Endocrinology; 1983 Feb; 112(2):550-7. PubMed ID: 6129133
    [No Abstract]   [Full Text] [Related]  

  • 51. Preclinical and clinical experiences with the role of somatostatin receptors in the treatment of pituitary adenomas.
    van der Hoek J; Lamberts SWJ; Hofland LJ
    Eur J Endocrinol; 2007 Apr; 156 Suppl 1():S45-S51. PubMed ID: 17413188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Silent corticotropic adenoma of pituitary gland--a case report.
    Lee SP; Lin HD; Wang GG; Ho DM; Lee LS; Ching KN; Chiang BN
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Mar; 45(3):196-9. PubMed ID: 2168265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does somatostatin have a role in the regulation of cortisol secretion in primary pigmented nodular adrenocortical disease (ppnad)? a clinical and in vitro investigation.
    Bram Z; Xekouki P; Louiset E; Keil MF; Avgeropoulos D; Giatzakis C; Nesterova M; Sinaii N; Hofland LJ; Cherqaoui R; Lefebvre H; Stratakis CA
    J Clin Endocrinol Metab; 2014 May; 99(5):E891-901. PubMed ID: 24512486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical detection of somatostatin receptor subtype 5 (SSTR-5) in cushing adenoma.
    Hassaneen W; Cahill DP; Fuller GN; Levine NB
    J Neurooncol; 2010 May; 98(1):151-2. PubMed ID: 19894022
    [No Abstract]   [Full Text] [Related]  

  • 55. Mapping of corticotropic cells in the normal human pituitary.
    Trouillas J; Guigard MP; Fonlupt P; Souchier C; Girod C
    J Histochem Cytochem; 1996 May; 44(5):473-9. PubMed ID: 8627004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Somatostatin receptors and their interest in diagnostic pathology.
    Volante M; Bozzalla-Cassione F; Papotti M
    Endocr Pathol; 2004; 15(4):275-91. PubMed ID: 15681851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulated resurfacing of a somatostatin receptor storage compartment fine-tunes pituitary secretion.
    Alshafie W; Francis V; Bednarz K; Pan YE; Stroh T; McPherson PS
    J Cell Biol; 2020 Jan; 219(1):. PubMed ID: 31825461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Somatostatin receptors and the associated intracellular machinery: the two sides of the coin.
    Campana C; Iyer AM; Ferone D; Gatto F; Hofland LJ
    J Endocrinol; 2024 Mar; 260(3):. PubMed ID: 38224333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Somatostatin: a potent inhibitor of ACTH-hypersecretion in adrenal insufficiency.
    Fehm HL; Voigt KH; Lang R; Beinert KE; Raptis S; Pfeiffer EF
    Klin Wochenschr; 1976 Feb; 54(4):173-5. PubMed ID: 1256005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Corticotropic cells of the hypophysis of the triton (Triturus marmoratus Latr.). Demonstration, by immunofluorescence, of a secretion related to the corticotropic hormone (beta-(1-24) corticotropin)].
    Doerr-Schott J; Dubois MP
    C R Acad Hebd Seances Acad Sci D; 1970 Oct; 271(17):1534-6. PubMed ID: 4322169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.